Pharmaceutical companies with the most orphan drugs

Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…


New patent for Novartis drug SCEMBLIX

Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Novartis drug SCEMBLIX appeared first on DrugPate…


Biotechblog